Cubillos-Ruiz et al. revealed that persistent activation of XBP1 in cancer-associated dendritic cells hindered its capacity to instigate anti-tumour T cells, subsequently catalyzing the progression of ovarian malignancies. Here, XBP1 is linked to neoplasm.